Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vactosertib in Locally Advanced Esophageal Adenocarcinoma
NCT06044311Phase 2Recruiting
- Start
- Sep 2024
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vactosertib in esophageal adenocarcinoma (EAC). Started Sep 2024; status: recruiting.
02
Drugs
vactosertib
03
Conditions
esophageal adenocarcinoma (EAC)
Beyond the preview
Go deeper on NCT06044311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06044311.